RIGH - Two New Tickers?
I've been asked this question about 1/2 dozen times today, here's my answer
provided months ago.
Pure speculation at this point, but...
And I know you are not big on this stock, but here's an example of what happened recently with a sister cannabis stock; bdpt was spun off and started trading about 3 months ago...
"Hemp, Inc. Announces Record Date for Issuance of Dividend Shares
LAS VEGAS, Jan. 10, 2014 (GLOBE NEWSWIRE) -- Hemp, Inc. is pleased to announce that its shareholders of record, as of close of business on January 13, 2014, will receive a dividend in the form of BioAdaptives, Inc. which is now, officially, a fully reporting development stage company. The S-1 filed, effective today, makes the 2,000,000 BioAdaptives, Inc. shares issued to Hemp, Inc. freely trading shares. This equates to approximately 1 share of BioAdaptives, Inc. for every 923 shares of Hemp, Inc. common, owned by a shareholder."
http://finance.yahoo.com/echarts?s=BDPT+Inter...T;range=3m
Someone asked me about two tickers across the puddle yesterday, here's what I had to say:
"My calculated guess - yes. Reading Angel's tea-leaves, based on the wordings in recent PR's -- it really sounds like this is how things will play out with Genius Bio Tech Corporation.
I see a separate trading symbol for GBTC (btw, that ticker is free and readily-available on the NYSE). I also see current investors receiving shares of GBTC based on the number of shares they currently hold in RIGH.
I also believe RIGH's new name, Bud Genius, Inc. will become BUDG. Angel has already emphatically emphasized (in person) and via email, no reverse split so that is beneficial to current shareholders.
So now armed with a capital pipeline. At least one Angel investor. The branching out of a new tech arm, under a new ticker. Then expansion of the testing business, falling under a new pot-related ticker, BUDG (and after today's press release, Angel is really serious about being the golden testing standard on the NYSE), and "No R/S" specifically stated by Angel...
How could this not benefit shareholders?
This all IMHO."
And here,
"Again, if this is the course taken (and I'm not 100% certain it will be, just speculating based on the public information surfacing), but current RIGH investors wouldn't necessarily be putting more cash into another ticker. New traders that come in after the new ticker stood up, would. Again, all speculations, but when I hear things like, "By partitioning our focus into distinct medical and general business units" and "creating a new subsidiary" and "being organized as a Delaware C-corp" and "board of directors have demanded that Genius Biotech Corporation should be fully reporting, audited, and Sarbanes-Oxley compliant" and "change the company’s name to Bud Genius, Inc. A new ticker symbol will be assigned after the name change has been officially recognized" and "The company is preparing forthcoming information regarding ongoing business strategies for Bud Genius and Genius Biotech Corporation" and "Bud Genius in Talks to List Subsidiary on OTC:BB" -- it sure sounds like two tickers is going to happen."
http://investorshangout.com/post/view?id=1906054
I've been asked this question about 1/2 dozen times today, here's my answer
provided months ago.
Pure speculation at this point, but...
And I know you are not big on this stock, but here's an example of what happened recently with a sister cannabis stock; bdpt was spun off and started trading about 3 months ago...
"Hemp, Inc. Announces Record Date for Issuance of Dividend Shares
LAS VEGAS, Jan. 10, 2014 (GLOBE NEWSWIRE) -- Hemp, Inc. is pleased to announce that its shareholders of record, as of close of business on January 13, 2014, will receive a dividend in the form of BioAdaptives, Inc. which is now, officially, a fully reporting development stage company. The S-1 filed, effective today, makes the 2,000,000 BioAdaptives, Inc. shares issued to Hemp, Inc. freely trading shares. This equates to approximately 1 share of BioAdaptives, Inc. for every 923 shares of Hemp, Inc. common, owned by a shareholder."
http://finance.yahoo.com/echarts?s=BDPT+Inter...T;range=3m
Someone asked me about two tickers across the puddle yesterday, here's what I had to say:
"My calculated guess - yes. Reading Angel's tea-leaves, based on the wordings in recent PR's -- it really sounds like this is how things will play out with Genius Bio Tech Corporation.
I see a separate trading symbol for GBTC (btw, that ticker is free and readily-available on the NYSE). I also see current investors receiving shares of GBTC based on the number of shares they currently hold in RIGH.
I also believe RIGH's new name, Bud Genius, Inc. will become BUDG. Angel has already emphatically emphasized (in person) and via email, no reverse split so that is beneficial to current shareholders.
So now armed with a capital pipeline. At least one Angel investor. The branching out of a new tech arm, under a new ticker. Then expansion of the testing business, falling under a new pot-related ticker, BUDG (and after today's press release, Angel is really serious about being the golden testing standard on the NYSE), and "No R/S" specifically stated by Angel...
How could this not benefit shareholders?
This all IMHO."
And here,
"Again, if this is the course taken (and I'm not 100% certain it will be, just speculating based on the public information surfacing), but current RIGH investors wouldn't necessarily be putting more cash into another ticker. New traders that come in after the new ticker stood up, would. Again, all speculations, but when I hear things like, "By partitioning our focus into distinct medical and general business units" and "creating a new subsidiary" and "being organized as a Delaware C-corp" and "board of directors have demanded that Genius Biotech Corporation should be fully reporting, audited, and Sarbanes-Oxley compliant" and "change the company’s name to Bud Genius, Inc. A new ticker symbol will be assigned after the name change has been officially recognized" and "The company is preparing forthcoming information regarding ongoing business strategies for Bud Genius and Genius Biotech Corporation" and "Bud Genius in Talks to List Subsidiary on OTC:BB" -- it sure sounds like two tickers is going to happen."
http://investorshangout.com/post/view?id=1906054
